MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    PD-PROP reporting in participants own words shows high burden of cognitive symptoms in early Parkinson Disease (PD)

    J. Purks, L. Arbatti, A. Hosamath, A. Amara, K. Anderson, L. Chahine, S. Eberly, D. Kinel, S. Mantri, S. Mathur, D. Oakes, D. Standaert, D. Weintraub, I. Shoulson, C. Marras (Rochester, USA)

    Objective: Describe the relative frequency of bothersome cognitive symptoms reported verbatim by people with PD in the Fox Insight online study. Background: Cognitive decline is…
  • 2023 International Congress

    Pain reduction in adults with cervical dystonia and moderate or severe baseline pain following repeated injections of incobotulinumtoxinA: an analysis of pooled data from phase 3 and 4 studies

    A. Albanese, J. Wissel, W. Jost, A. Castagna, M. Althaus, G. Comes, A. Scheschonka, M. Vacchelli, H. Jinnah (Rozzano, Italy)

    Objective: To assess pain reduction in incobotulinumtoxinA (incoA)-treated adults with cervical dystonia (CD)-related moderate or severe pain at baseline using pooled data from four phase…
  • 2023 International Congress

    Factors influencing voice function after deep brain stimulation in Parkinson’s disease

    H. Jergas, T. Tsuboi, V. Stopic, D. Nakatsubo, C. Hennen, S. Maesawa, J. Einhaus, R. Saito, V. Visser-Vandewalle, M. Katsuno, M. Barbe (Cologne, Germany)

    Objective: To assess the effect of Deep Brain Stimulation (DBS) on self-perceived changes of voice function in Parkinson’s disease (PD). Background: To date, the effect…
  • 2023 International Congress

    A minimal clinically important difference for UHDRS® Total Maximal Chorea score as a measure of chorea severity in Huntington disease

    E. Furr Stimming, D. Claassen, E. Kayson, J. Goldstein, H. Zhang, O. Klepitskaya, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To establish a minimal clinically important difference (MCID) for the Unified Huntington Disease Rating Scale (UHDRS®) Total Maximal Chorea (TMC) score as a measure…
  • 2023 International Congress

    PARKinSOUND: Impact of participation in an orchestra in patients with Parkinson’s disease

    S. Marques, S. Lopes, A. Ferreira, A. Silva, G. Carneiro, S. Varanda, P. Santos, A. Goios, M. Rodrigues (Braga, Portugal)

    Objective: To investigate the impact of participation in a community orchestra on motor and non-motor symptoms in PD patients. Background: Music undoubtfully contributes to our…
  • 2023 International Congress

    Cognitive Interference in Postural Control as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders.

    R. Lloyd, C. Fearon, R. Reilly (Dublin, Ireland)

    Objective: The purpose of this research is to explore whether Progressive supranuclear palsy (PSP) patients display distinct sway patterns compared to idiopathic Parkinson's disease (PD)…
  • 2023 International Congress

    DaT Scan Positive Parkinson’s Disease in a Patient with Anti-MuSK Positive Myasthenia Gravis

    G. Andraos, N. Ahmed, V. Veerappan (Greer, USA)

    Objective: We present a unique clinical case of antibody positive Muscle Specific Kinase (MuSK) Myasthenia Gravis and DaT scan positive Parkinson's Disease to highlight the…
  • 2023 International Congress

    Correlates of gait impairment in parkinson’s disease

    E. Abdeldayem, A. Shalash (Cairo, Egypt)

    Objective: Assess gait dysfunction in patients with PD and its correlation with clinical (motor and non-motor symptoms) and radiological findings. Background: Gait impairment is one…
  • 2023 International Congress

    Understanding caffeine consumption in Huntington’s Disease

    J. Adrissi, S. Brooker, A. Mcbride, D. Larson, E. Gausche, D. Bega (Los Angeles, USA)

    Objective: The purpose of this study is to better understand the amount of caffeine consumption in people with HD and the subjective motivations and consequences…
  • 2023 International Congress

    Pre-surgical correlates of QoL (PDQ-39) in a DBS eligible PD population

    J. Jimenez-Shahed, A. Berg, J. Kirk, M. York, J. Schwalb, M. Siddiqui, J. Mcinerney (New York, USA)

    Objective: To investigate the pre-surgical correlates of quality of life (QoL) in patients with Parkinson's disease (PD) eligible for deep brain stimulation (DBS). Background: Optimizing…
  • « Previous Page
  • 1
  • …
  • 325
  • 326
  • 327
  • 328
  • 329
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley